2021
DOI: 10.5114/pedm.2021.105298
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone improves short stature in children with Shwachman-Diamond syndrome

Abstract: Introduction Shwachman-Diamond syndrome (SDS) is a rare, autosomal recessive multisystemic disorder characterized by pancreatic insufficiency and bone marrow failure. Short stature is a recognized feature of SDS syndrome; however, systemic data concerning recombinant human growth hormone (rGH) treatment are limited. Aim of the study To assess the effect of rGH treatment in patients with SDS. Material and Methods Retrospective data were collec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…Growth abnormalities are commonly observed in patients with SDS. 42 These may present as intrauterine growth restriction (IUGR) or short stature. IUGR or short stature were observed in 90% of patients with SBDS variants and the 50 th percentile of the SDS population correspond to the 3 rd percentile of the healthy population.…”
Section: Clinical Featuresmentioning
confidence: 99%
“…Growth abnormalities are commonly observed in patients with SDS. 42 These may present as intrauterine growth restriction (IUGR) or short stature. IUGR or short stature were observed in 90% of patients with SBDS variants and the 50 th percentile of the SDS population correspond to the 3 rd percentile of the healthy population.…”
Section: Clinical Featuresmentioning
confidence: 99%